Welcome : Guest

Dong-A Socio Holdings Co., Ltd. (Korea) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Dong-A Socio Holdings Co., Ltd., which is principally involved in Pharmaceuticals. Illustrated with 276 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-63259
Price: $3500
Company Type: Public
Pages: 281
Date: September 2015
Market Data Tables: 276

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Pharmaceuticals......6
Table 1: Pharmaceutical Consumption by Category in Australia (2014) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......6
Table 2: Pharmaceutical Drugs Market by Category in Germany (2014) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......7
Table 3: Pharmaceuticals Market by Region in European Union (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Great Britain, Italy, Spain, and Others......8
Table 4: Pharmaceuticals Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......9
Table 5: Pharmaceuticals by Therapeutic Area in China (2014) - Percentage Market Share Breakdown by Value Sales for Alimentary & Metabolism, Anti-Infective, Cardiovascular, Central Nervous System, Neoplasm, and Others......10
Table 6: Pharmaceuticals Market by Product in the US (2014) - Percentage Share Breakdown by Value Sales for Abilify, AdvairDiskus, Crestor, Cymbalta, Enbrel, Humira, Nexium, Remicade, and Others......11
Table 7: Pharmaceuticals Market by Therapeutic Area in China (2014) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......12
Table 8: Pharmaceuticals Prescription Market by Product in the US (2014) - Percentage Share Breakdown by Value Sales for Amlodipine, Hydrocodone/Acetaminophen, Levothyroxine, Lisinopril, Metformin, Metoprolol, Omeprazole, Salbutamol, Simvastatin, and Others......13
Table 9: Pharmaceuticals Sales by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......14
Table 10: Speciality Pharmaceuticals Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......15
Table 11: Research & Development Spending in Pharmaceuticals by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......16
Table 12: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2014) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......17
Table 13: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......18
Table 14: Therapeutic Classes Market by Segment in the US (2014) – Percentage Market Share Breakdown by Value Sales for Antidiabetics, Antihypertensives, Autoimmune Diseases, HIV Antivirals, Lipid Regulators, Mental Health, Oncologics, Pain, Respiratory Agents, and Others......19
Table 15: Therapeutic Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......20
Table 16: Drug Market by Category in Asia-Pacific (2014) - Percentage Share Breakdown by Value Sales for Branded Generics, Originals and Un-Branded Generics......21
Table 17: Drugs Market by Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Specialty Drugs, and Traditional Oral Drugs......22
Table 18: Drugs Market by Region Worldwide (2014) - Percentage share Breakdown by Value Sales for Switzerland, US, Others Europe, and Rest of World......23
Table 19: Drugs Payment Market by Payer in Australia (2014) - Percentage Share Breakdown by Value Sales for Government, and Patients......24
Table 20: Government Spending on Drugs by Category in Australia (2014) – Percentage Market Share Breakdown by Volume for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensive, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmological, Psych analeptics, Psycholeptics, and Others......25
Table 21: Government Spending on Drugs by Category in Australia (2014) - Percentage Market Share Breakdown by Sales for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensive, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmological, Psych analeptics, Psycholeptics, and Others......26
Table 22: Speciality Drug Sales by Therapeutic Category in the US (2014) – Percentage Market Share Breakdown by Value for Anticoagulants, Cancer, Growth Deficiency, Hepatitis C, HIV, Inflammatory Conditions, Multiple Sclerosis, Pulmonary Hypertension, Respiratory Conditions, Transplant and Others......27
Table 23: Leading Pharmaceuticals Suppliers to Germany by Region Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Belgium, France, Great Britain, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, USA, and Others......28
Prescription Drugs......29
Table 24: Prescription Drugs Market in the US (2014) in US$ Million......29
Table 25: Prescription Drugs Ad Spending through Media in the US (2014) in US$ Thousand......30
OTC Drugs......31
Table 26: OTC Drug Sales by Category in China (2014) - Percentage Market Share Breakdown by Value for Anti-Inflammatory, Cold, Gastrointestinal, Gynecological, Minerals, Tonics, Vitamins, Supplements, and Others......31
Table 27: OTC Drugs Market by Channel in China (2014) - Percentage Share Breakdown by Value Sales for Clinics, Community Hospital, General Hospital, Pharmacy, Supermarket, and Others......32
Table 28: OTC Market (Private Label and Others) by Region Worldwide (2014) - Percentage Share Breakdown by Values Sales for Australia, Canada, Chile, France, Germany, Israel, Japan, Netherlands, Russia, United Kingdom, USA and Rest of the World......33
Generic Drugs......34
Table 29: Generic Pharmaceuticals Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......34
Table 30: Global IV Generics Drug Market by Value Sales (2014) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others......35
Biologics......36
Table 31: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......36
Table 32: Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Biologics, and Chemicals......37
Table 33: Biologics Therapeutic Classes Market by Category in China (2014) – Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......38
Antibiotics......39
Table 34: Antibiotics Market by Category in China (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporin’s, Macrolides, Penicillin’s, Quinolones, and Others......39
Table 35: Antibiotics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporin’s, Macrolides, Penicillin’s, Quinolones, and Others......40
Anticoagulants......41
Table 36: Anticoagulation Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Direct Thrombin Inhibitors (DTI), Low-Molecular-Weight Heparin (LMWH), Unfractionated Heparin (UFH), Vitamin K Antagonists (VKA) and Others......41
Table 37: Anticoagulation Therapy by Segment Worldwide (2014) - Percentage Market Share Breakdown by Value for Acute Coronary Syndrome and Myocardial Infarction, Prevention of Venous Thromboembolism, Stroke Prevention in Atrial Fibrillation, Venous Thromboembolism Treatment and Other Primary Prevention......42
Cancer Drugs......43
Table 38: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......43
Table 39: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immuno stimulant, Plant Alkaloids, and Others......44
Table 40: Cancer Care Expenditure by Site Worldwide (2014) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......45
Table 41: No. of Bladder Cancer Patients by Category in the US (2014) – Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......46
Table 42: No. of Cancer Patients Death by Type in the US (2014) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......47
Table 43: Number of Cancer Patients by Type in the US (2014) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......48
Table 44: Number of Cancer Patients by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......49
Table 45: Female Mortality by Cancer Type in China (2014) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......50
Table 46: No. of Solid Cancer Tumor Patients by Type Worldwide (2014) – Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......51
Table 47: Skin Cancer by Type Worldwide (2014) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......52
Dermatological Drugs......53
Table 48: Dermatological Drug Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......53
Table 49: Dermatology Biologics Market by Product Type Worldwide (2014) – Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......54
Table 50: Dermatology Drugs Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......55
Diabetes Drugs......56
Table 51: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) – Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......56
Gaucher Disease Drugs......57
Table 52: Market Shares of Drugs for Gaucher Disease by Region Worldwide (2014) - Percentage Breakdown by Value for European Union, United States and Rest of World......57
Hemophilia Drugs......58
Table 53: Continuous Prophylaxis (Moderate) Treatment for Hemophilia A Patients by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......58
Table 54: Continuous Prophylaxis Treatment (Severe) for Hemophilia A Patients by Age Group Worldwide (2014) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......59
Table 55: Intermittent Prophylaxis (Moderate Patient Equivalent) Treatment for Hemophilia A Patients by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......60
Table 56: Intermittent Prophylaxis (Severe Patient Equivalent) Treatment for Hemophilia A Patients by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......61
Table 57: On-Demand (Moderate Patient) Treatment for Hemophilia A Patients by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......62
Table 58: On-Demand (Severe Patient) Treatment for Hemophilia A Patients by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......63
Infectious Disease Drugs......64
Table 59: Infectious Disease Drugs Market by Category Worldwide (2014) – Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporin’s, Macrolides, Penicillin’s, Quinolones, and Others......64
Table 60: Infectious Disease Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......65
Multiple Sclerosis......66
Table 61: Multiple Sclerosis Disease Occurrence by Type Worldwide (2014) - Percentage Breakdown by Volume for Begin MS, Primary Progressive MS, Relapsing-Remiting MS, and Secondary Progressive MS......66
Table 62: Multiple Sclerosis Patient Care Expenditure by Category Worldwide (2014) - Percentage Breakdown by Value for Adaptations, Ambulatory Care, Disease Modifying Drugs, Early Retirement, Hospital Inpatient Care, Informal Care, Prescription and OTC Drugs, Services, Sick-leave and Reduced Working Time, and Tests.......67
Table 63: No. of Tcelna (Imilecleucel-T) Secondary Progressive Multiple Sclerosis Patients by Category in the US (2014) - Percentage Breakdown for Primary Progressive MS Patients, Relapsing-Remitting MS Patients, and Secondary-Progressive MS Patients......68
Pulmonary Arterial Hypertension (PAH)......69
Table 64: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......69
Table 65: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2014) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......70
Table 66: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2014) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......71
Table 67: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2014) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy ......1
Table 68: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......73
Table 69: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2014) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......74
Table 70: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2014) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......75
Table 71: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2014) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......76
Other Pharmaceuticals......77
Table 72: Anatomical Therapeutic Chemical (ATC-3) Indications Market in Germany (2014) - Percentage Share Breakdown by Value Sales for A10C Human Insulin and Analogs, C09D Angiotensin II Antagonists, L01X Other Antineoplastic Agents, L03B Interferons, L04B Anti-TNF Preparations, L04X Other Immuno suppressants, N02A Analgesics, Narcotics, N03A Antiepileptic’s, N05A Antipsychotics, T02D Diabetes Tests, and Others......77
Table 73: Anatomical Therapeutic Chemical (ATC-3) Indications Market in Germany (2014) - Percentage Share Breakdown by Volume Sales for A02B Ulcer Treatments, B01C Anti-Platelet Treatments, C07A Beta-Blockers, Pure, M01A Anti-Phlog /Anti-Rheumatic, Non-Steroid, M02A Anti-Rheumatic and Analgesics, Topical, N02B Other Analgesics, R01A Nasal Preparations, Topical, R02A Throat Preparations, R05C Expectorants without Anti-Infect ants, V03X Other Therapeutic Preparations, and Others......78
Table 74: Bone Disease Drugs Market by Therapy Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bisphosphonates, Bone Oncology, Hormonal Agents, SERMS, and Others......79
Table 75: Brachytherapy Treatment (Body Sites) Market in the US (2014) – Percentage Share Breakdown by Value Sales for Breast, Liver, Prostate and Others......80
Table 76: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Anti- Inflammatory, Biologics, and Immuno modulatory......81
Table 77: Injectable Products Market by Type in Europe (2014) - Percentage Breakdown by Value Sales for Biologics, Biosimilars, Branded Injectable and Generic Injectable......82
Table 78: Intravenous Immunoglobulin (IVIG) Therapy by Disorders in the US (2014) - Percentage Market Share Breakdown by No. of Indications for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Chronic Lymphocytic Leukemia (CLL), Idiopathic Thrombocytopenic Purpura (ITP), Mismatch Negativity (MMN), Pelvic Inflammatory Disease (PID), and Others......83
Table 79: Kidney Disease Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp and Others......84
Table 80: Psoriasis Disease by Type Worldwide (2014) - Percentage Market Share Breakdown by Volume for Palmoplantar Psoriasis, Plaque Psoriasis, Psoriasis of Mucous Membranes, Psoriatic Arthritis, and Pustular Psoriasis......85
Table 81: Women's Health Drugs Market by Category Worldwide (2014) – Percentage Share Breakdown by Value Sales for Contraceptives, Hormone Therapy, Fertility, and Others......86
Table 82: No. of Onychomycosis Patients by Category Worldwide (2014) – Percentage Market Share Breakdown for Debridement, Oral Medication (Primarily Lamisil), Topical Treatments (Penlac and OTC Products), and Untreated......87
Table 83: Antipsychotic Drugs Market by Disorder in the US (2014) – Percentage Breakdown by Value for Anxiety, Bipolar, Disorder, Major, Depression, Schizoaffective Disorder, Schizophrenia, and Other Indications......88
Table 84: Antiviral Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antiviral Drugs, Monoclonal Antibodies, Vaccines and Others......89
Table 85: Meropenem Drug Sales by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for European Union, US and Rest of World......90
Table 86: Imi-Cila Drug Sales by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for European Union, US and Rest of World......91
Table 87: Antimetabolites Market by Type Worldwide (2014) - Percentage Share Breakdown by Value for Capecitabine, Gemcitabine, Pemetrexed, TS-1, and Others......92
Table 88: Chronic Kidney Disease Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp and Others......93
Table 89: Dialysis Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Arane , EPO alfa/beta biosimilars and Others......94
Table 90: Formulations Sales by Category in India (2014) - Percentage Market Share Breakdown by Value for Anti Infective, Anti-diabetic, Central Nervous System (CNS), Cyclic Vomiting Syndrome (CVS), Gastro Intestinal, Pain Management, and Others......95
Table 91: Hemodialysis Market by Drug in the US ((2014) - Percentage Share Breakdown by Value Sales for Aranesp, Biosimilar, Epogen, and Others (Mircera)......96
Table 92: Insulin Market by Generation in China (2014) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......97
API for Small Molecules......98
Table 93: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2014) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......98
Medical Devices & Diagnostics (MD&D)......99
Table 94: Medical Device and Diagnostics Market by Product Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Anesthesia & Respiratory, Cardiology, Dental, Diabetic Care, Diagnostic Imaging, Drug Delivery, Ear, Nose, and Throat (ENT), Endoscopy, General & Plastic Surgery, In Vito Diagnostics, Nephrology, Neurology, Opthalmics, Orthopedics, Wound Management, and Others......99
Table 95: Medical Devices & Diagnostics (MD&D)'s Market by Country Worldwide (2014) - Percentage Share Breakdown by Value Sales for Brazil, Canada, China, France, Germany, Italy, Japan, Russia, Spain, U.S., UK, and Others......100
Table 96: Medical Devices Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cardiovascular, Dental, Diabetes SMBG & Int. Sol, Drug Delivery, Endoscopy, Energy- Based, Radiotherapy, Imaging, In-Vitro Diagnostics, Orthopedics, Surgical Instrument, Urology & Renal, Vision, Wound Care, and Others......101
Table 97: Global Medical Device and Diagnostics Market (2014) in US$ Million......102
Table 98: Medical Equipment Market by Type in India (2014) - Percentage Share Breakdown by Value for Home care, Imaging (CT (Computed Tomography) Scan, Doppler, MRI (Magnetic Resonance Imaging), Ultrasound, X-Ray, Others), Patient Monitoring, and Therapeutic......103
Medical Imaging Equipment......104
Table 99: Medical Imaging Equipment Market by Region Worldwide (2014) – Percentage Share Breakdown by Value Sales for Asia-Pacific (APAC), China, Europe, Latin America (LATAM), North America, and Rest of World (RoW)......104
Table 100: Medical Imaging Equipment Market by Segment in Asia Pacific (2014) - Percentage Share Breakdown by Value Sales for Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine, Ultrasound, and X-ray......105
Table 101: Medical Imaging Equipment Market by Segment in Australia (2014) - Percentage Share Breakdown by Value Sales for Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine, Ultrasound, and X-ray......106
Table 102: Medical Imaging Equipment Market by Segment in China (2014) – Percentage Share Breakdown by Value Sales for Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine, Ultrasound, and X-ray......107
Table 103: Medical Imaging Equipment Market by Segment in India (2014) – Percentage Share Breakdown by Value Sales for Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine, Ultrasound, and X-ray......108
Table 104: Medical Imaging Equipment Market by Segment in Japan (2014) – Percentage Share Breakdown by Value Sales for Computed Tomography (CT), Diagnostic Ultrasound, Magnetic Resonance Imaging (MRI), Nuclear Medicine, and X-ray......109
Table 105: Medical Imaging Equipment Market by Segment in South Korea (2014) - Percentage Share Breakdown by Value Sales for Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine, Ultrasound, and X-ray......110
Table 106: Medical Imaging Market by Region in Asia Pacific (2014) - Percentage Share Breakdown by Value Sales for Australia, China, India, Japan, and South Korea......111
Table 107: Medical Imaging System (MIS) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Greater China, North America, Western Europe, and Others......112
Table 108: Medical Imaging System (MIS) Market by Test Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Computed Tomography (CT) and X-Rays, MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography) and Ultrasound......113
X-Ray Equipment......114
Table 109: X-ray Equipment (Analogue & Digital Radiography) Market by Segment in India (2014) - Percentage Share Breakdown by Volume Sales for Fixed, Mobile, and Retrofit......114
Table 110: X-ray Equipment Market by Type in India (2014) - Percentage Share Breakdown by Volume Sales for Analogue, and Digital Radiography......115
Ultrasound Equipment......116
Table 111: Ultrasound Black and White (B/W) Equipment Market by Type in India (2014) - Percentage Share Breakdown by Value Sales for Portable, and Stand-Alone......116
Table 112: Ultrasound Black and White (B/W) Equipment Market by Type in India (2014) - Percentage Share Breakdown by Volume Sales for Portable, and Stand-Alone......117
Table 113: Ultrasound Equipment Market by Channel Worldwide (2014) - Percentage Share Breakdown by Value Sales for Direct Sales and Distributor Sales......118
Table 114: Ultrasound Equipment Market by Channel Worldwide (2014) - Percentage Share Breakdown by Volume Sales for Direct Sales and Distributor Sales......119
Table 115: Ultrasound Equipment Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for China, India, Japan, Latin America, North America, Western Europe, Other Asia-Pacific and Other EMEA (Europe, the Middle East and Africa)......120
Table 116: Ultrasound Equipment Market by Segment Worldwide (2014) – Percentage Share Breakdown by Value Sales for High-End Compact, High-End/Premium, Low-End, Mid-Range and Other Compact......121
Table 117: Ultrasound Equipment Market by Type in India (2014) - Percentage Share Breakdown by Value Sales for Black and White (B/W), and Color Doppler......122
Table 118: Ultrasound Equipment Market by Type in India (2014) - Percentage Share Breakdown by Volume Sales for Black and White (B/W), and Color Doppler......123
In Vitro Diagnostics (IVD)......124
Table 119: Global In Vitro Diagnostics (IVD) Market by Area (2014) - Percentage Share Breakdown by Value Sales for Clinical Chemistry, Flow Cytometry, Hematology & Blood, Histology & Cytology, Immunoassays, Microbiology & Virology, Molecular Diagnostics and Point-of-Care Testing......124
Table 120: In Vitro Diagnostics (IVD) Laboratory Market by Segment in France (2014) - Percentage Share Breakdown by Value Sales for Instruments, and Reagents......125
Table 121: In Vitro Diagnostics (IVD) Market by Region in Europe (2014) - Percentage Share Breakdown by Value Sales for Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Spain, Switzerland, UK, and Rest of the Europe......126
Table 122: In Vitro Diagnostics (IVD) Laboratory Market by Customer in France (2014) - Percentage Share Breakdown by Value Sales for Establishment Français du Sang (EFS), Private Laboratories, Public and Private Hospitals, and Others......127
Molecular Diagnostics (MDx)......128
Table 123: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2014) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......128
Table 124: Global Molecular Diagnostics (MDx) Market by Region (2014) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......129
Table 125: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......130
Table 126: Molecular Diagnostics (MDx) Market by Technology Worldwide (2014) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......131
Table 127: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......132
Table 128: Molecular Diagnostics (MoDx) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......133
Table 129: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), methicillin-resistant S. aureus (MRSA), Viral Load, and Others......134
Table 130: Molecular Diagnostics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......135
Table 131: Molecular Diagnostics Market by Segment in the US (2014) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......136
Table 132: Molecular Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......137
Table 133: Molecular Diagnostics Test Market by Type in Europe (2014) - Percentage Share Breakdown by Volume for Chlamydia Trachomatis (CT) - Neisseria Gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-Resistant Staphylococcus Aureus (MRSA) and Others......138
Table 134: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2014) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......139
Logistics......140
Table 135: Logistics Market by Region in Europe (2014) - Percentage Share Breakdown by Value Sales for Austria, Belgium, Eastern Europe, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, UK, and Others......140
Table 136: Logistics Market by Segment in Australia (2014) - Percentage Share Breakdown by Value Sales for Bond Facilities, Cold Storage, Distribution Services, General Warehousing, Self-Storage and Others......141
Table 137: South African Logistics Industry by End Market (2014) - Percentage Share Breakdown for Automotive, Construction, Fast-Moving Consumer Goods & Retail, Industrial Products, Mining & Agriculture, Petrochemicals & Chemicals, and Others......142
Table 138: Contract Logistics Market by Region in Asia Pacific (2014) - Percentage Share Breakdown by Value Sales for Australia, and New Zealand, Auto Logistics, Government, Greater China, Indian subcontinent, South East Asia and Rest of Asia......143
Table 139: Third-Party Logistics (3PL) Market by Product Segment in the U.S. (2014) - Percentage Share Breakdown by Value for Dedicated Contract Carriage, Domestic Freight Management, International Freight Management and Value-Added Warehousing & Distribution......144
Table 140: Third-Party Logistics Demand by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Dedicated Contract Carriage, Integrated Solutions, Intermodal, International, Lead Logistics Provider, Supply Chain Mgmt, Transportation Mgmt, Value Added TM or VW, Warehousing, and Others......145
Table 141: Third-Party Logistics(3PL) Market by Country in Asia-Pacific (2014) - Percentage Share Breakdown by Value for Association of Southeast Asian Nations (ASEAN), Australia, China, India, Japan, Korea, Taiwan, and Others......146
Real Estate......147
Table 142: Real Estate Classifieds Market by Category in the UK (2014) - Percentage Share Breakdown by Value for Online, and Print......147
Table 143: Real Estate Classifieds Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Commercial, Developers, Residential, and Others......148
Table 144: Online Residential Real Estate Classifieds Providers in Australia (2014) - Percentage Breakdown by Value for Domain.com, REA Group Ltd, and Realestateview.com.au Ltd......149
Table 145: Residential Real Estate Classifieds Market by Category in Australia (2014) - Percentage Share Breakdown by Value for Online, and Print......150
Table 146: Real Estate Advertising Market by Type in Australia (2014) - Percentage Share Breakdown by Value for Metropolitan Magazines, Metropolitan Newspapers, Regional Publications, Suburban Magazines, Suburban Newspapers, and Others......151
Table 147: Spending on Real Estate Advertising in the US (2014) in US$ Million......152
Table 148: Online Real Estate Spending on Advertising by Medium in the US (2014) - Percentage Share Breakdown by Value Sales for Broadcast TV, Cable TV, Direct Mail, Newspapers, Other Print, Out of Home, Radio, and Others......153
Glass Packaging......154
Table 149: Global Glass Packaging Market (2014) in US$ Million......154
Table 150: Glass Packaging Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia, Ocean & MENA, Europe, North America, and South & Central America......155
Table 151: Glass Packaging End Use Market by Segment Worldwide (2014) – Percentage Share Breakdown by Value Sales for Beer, Food, Liquor, Pharma, and Others......156
Table 152: Glass Packaging Market by Type Worldwide (2014) - Percentage Share Breakdown for Moulded Glass, and Tubular Glass......157
Table 153: Moulded Glass Packaging Market by End-Use Segment Worldwide (2014) - Percentage Share Breakdown for Cosmetics & Perfumery, Food & Beverages, and Pharmaceuticals......158
Table 154: Glass Container End Use Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Beer, Food, NAB, Spirits, and Wine......159
Table 155: Glass Container Market by Region Worldwide (2014) – Percentage Breakdown by Value Sales for Asia-Pacific, Europe, North America, South America, and Others......160
Table 156: Glass Shipments End Market by Segment in the US (2014) - Percentage Share Breakdown by Value Sales for Beer, Beverages, Food, Liquor, Ready to Drink, Wine, and Others......161
Table 157: Container Glass Consumption Market by Segment in India (2014) – Percentage Share Breakdown for Beverages, Cosmetics, Food Products, Liquor & Beer, and Pharmaceuticals......162
Rigid Plastics Packaging......163
Table 158: Rigid Plastics Packaging Consumption Market by Product Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bottles, Trays & Containers, Tubs & Pots, and Others......163
Table 159: Rigid Plastics Packaging Consumption End Market by Type Worldwide (2014) - Percentage Share Breakdown for Consumer Non-Food, Drinks, Food, and Others......164
Pharmaceuticals......165
Table 160: Market Shares of Leading New Pharmaceutical Licensed Drug Companies by Value Sales Worldwide (2014) - Percentage Breakdown for C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company, Gilead Sciences, and Others......165
Table 161: Market Shares of Leading Over-The-Counter (OTC) Pharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Boehringer Ingelheim Group, Hypermarcas S.A., Procter & Gamble Pharmaceuticals, Inc., Sanofi - Medley Indústria Farmacêutica Ltda, Takeda Pharmaceutical Company Limited and Others......166
Table 162: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......167
Table 163: Market Shares of Leading Drug Providers in the US (2014) – Percentage Breakdown by Value for Clearwater Paper Corporation and Other Private Label......168
Table 164: Market Shares of Leading Drug Distributors Worldwide (2014) -Percentage Breakdown by Value for AmerisourceBergen Corporation, Express Scripts, McKesson Corporation, Metro Medical and Others......169
Prescription Drugs......170
Table 165: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......170
Table 166: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......171
Generic Drugs......172
Table 167: Market Shares of Leading IV Generic Drugs Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Baxter International, Inc., Fresenius Kabi AG, Hospira, Inc., Novartis International AG, Sun Pharmaceutical Industries Limited and Others......172
Table 168: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd, Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......173
Table 169: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharma care Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others......174
Table 170: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Euro farma Laboratories, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......175
Table 171: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......176
Biopharmaceuticals......177
Table 172: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson Ltd., Lonza Group Ltd, Pfizer, Inc., Sanofi S.A. and Others......177
Cancer Drugs......178
Table 173: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......178
Gastro Intestinal Drugs......179
Table 174: Market Shares of Leading Gastro Intestinal Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd, and Others......179
Table 175: Market Shares of Leading Gastrointestinal Remedy Products Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for GlaxoSmithKline plc., Johnson & Johnson, Novartis A G, Prestige Brands Holdings, Inc.,Procter & Gamble Co., Private Label and Others......180
Gaucher Disease Drugs......181
Table 176: Market Shares of Leading Drugs for Gaucher Disease Worldwide (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......181
Table 177: Market Shares of Leading Drugs for Gaucher Disease in EU (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......182
Table 178: Market Shares of Leading Drugs for Gaucher Disease in the US (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......183
Hepatitis Drugs......184
Table 179: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......184
Table 180: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......185
Table 181: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......186
Table 182: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......187
Table 183: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-LaRoche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......188
Injectable......189
Table 184: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......189
Table 185: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......190
Table 186: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc.,Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......191
Table 187: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......192
Table 188: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......193
Insulin......194
Table 189: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......194
Table 190: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......195
Table 191: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd. , Novo Nordisk, Sanofi S.A. , Shanghai Fosun Pharmaceutical Group Co, Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......196
Table 192: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......197
Table 193: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Cadila Pharmaceuticals Limited, Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Limited, Pfizer India Limited, Ranbaxy Laboratories Limited, Sanofi India Limited, Shreya Life Sciences Pvt. Ltd, USV Limited and Wockhardt Ltd.......198
Table 194: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......199
Table 195: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......200
Table 196: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd. and Others......201
Table 197: Insulin Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog) and Rh Insulin......202
Diabetes Drugs......203
Table 198: Market Shares of Leading Drug Sales for GLP-1 based Diabetes Worldwide (2014) - Percentage Breakdown by Value for Albilgutide, Bydureon, Byetta, Dulaglutide, Lixumia and Victoza......203
Table 199: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd. and Others......204
Pain Drugs......205
Table 200: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......205
Other Pharmaceuticals......206
Table 201: Market Shares of Leading Allergy Care Product Companies by Value Sales in the US (2014) - Percentage Breakdown for Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Sanofi S A, Private Label and Others......206
Table 202: Market Shares of Leading Alzheimers Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......207
Table 203: Market Shares of Leading Bone Diseases Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, Sanofi S.A., and Others......208
Table 204: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd, and Others......209
Table 205: Market Shares of Leading Granulocyte Colony-Stimulating Factor (GCSF) Companies in China (2014) - Percentage Share Breakdown by Value for Amoytop Biotech Co, Ltd., Harbin Pharmaceutical Group Co, Ltd. , Kyowa Hakko Kirin Co, Ltd., Qilu pharmaceutical Co, Ltd., Zhejiang Huahai Pharmaceutical Co, Ltd., and Others......210
Table 206: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......211
Table 207: Market Shares of Leading Haemophilus B Conjugate Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hiberix), and Others......212
Table 208: Market Shares of Leading Human Albumin Companies in China (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., Chengdu Institute of Biological Products Co, Ltd., China Biologic Products, Inc., CSL Behring, Grifols, S.A., and Others......213
Table 209: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......214
Table 210: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......215
Table 211: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......216
Table 212: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......217
Table 213: Market Shares of Leading Intravenous Immunoglobulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co, Ltd., Ningbo Boya Medical Equipment Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Shanghai RAAS Blood Products Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......218
Table 214: Market Shares of Leading Nerve Growth Factor (NGF) Companies in China (2014) - Percentage Share Breakdown by Value for Ningbo Hi-Tech Biochemicals Co, Ltd., Staidson (Beijing) Biopharmaceuticals Co, Ltd., Xiamen Bioway Pku Co, Ltd., and Others......219
Table 215: Market Shares of Leading Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc. (AMGN), Eli Lilly And Co (LLY), Merck & Co., Inc. (MRK), Novartis AG (NVS), Sanofi SA (SNY), Warner Chilcott Plc (WCRX), and Others......220
Table 216: Market Shares of Leading Factor VIII (With Recombinant Factor) Companies in China (2014) - Percentage Breakdown by Value for Bayer AG, China Biologic Products, Inc., Green Cross Corporation, Hualan Biological Engineering, Inc., and Shanghai RAAS Blood Products Co, Ltd.......221
Table 217: Market Shares of Leading Factor VIII (Without Recombinant Factor) Companies in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., Green Cross Corporation, Hualan Biological Engineering, Inc., and Shanghai RAAS Blood Products Co, Ltd.......222
Table 218: Market Shares of Leading Gadeopentetate Dimengulumine Injection Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Bayer HealthCare AG, Beijing BeiLu Pharmaceutical Co., Ltd., Consun Pharmaceutical Group Ltd., General Electric Company, Shanghai Xudong Haipu Pharmaceutical Co., Ltd. and Others......223
Table 219: Market Shares of Leading Hemophilia Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Bayer AG, CSL Limited, Grifols, S.A., Kedrion S.p.A, Novo Nordisk A/S, Octapharma AG, and Pfizer, Inc.......224
Table 220: New Prescription Market for Atypical Antipsychotic Drugs in the US (2014) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......225
Table 221: Market Shares of Leading Narcotic Drugs Manufacturers by Value Sales in China (2014) - Percentage Breakdown for Beijing Mundipharma Ltd., China National Medicines Corporation, Impofstoffwerk Dessau Tomau GmbH, Notheast Pharmaceutical Group ., Ltd., Shanhaiguan Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co .,Ltd., The Grunenthal Group, Weihal Lotus Pharmaceutical Co., Ltd, Wuhan HumanWell Bi-Tech industry Co, Ltd, Xian-Janseen Pharmaceutical Ltd, and Others......226
Table 222: Narcotic Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value Sales for Butorphanol, Daphine Giraldii Nitsche, Dihydrocodeine/Paracetamol and dihydrocodeine, Fentanyl, Morphine, Oxycodone Acetaminophen, Tramadol, and Others......227
Table 223: Market Shares of Leading Glargine Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Pfizer India Limited, Sanofi India Limited and Wockhardt Ltd.......228
Table 224: Global Sports Medicine / Arthroscopy Market by Value Sales (2014) - Percentage Share Breakdown for Arthrex, Inc., ArthroCare Corporation, Biomet, Inc., CONMED Corporation, and Johnson & Johnson, RTI Surgical, Inc., Smith & Nephew Plc, and Stryker Corporation......229
Table 225: Market Shares of Leading Cough, Cold Allergy Medicine Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., Reckitt Benckiser Plc, and Others......230
Table 226: Market Shares of Leading Cough/Cold Remedy Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Johnson & Johnson, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser plc., Sanofi S.A. Private Label, and Others......231
Table 227: Market Shares of Leading Cyclic Vomiting Syndrome (CVS) Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd, and Others......232
Table 228: Market Shares of Leading Dermatological Products Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......233
Table 229: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......234
Table 230: Market Shares of Leading Docetaxel Companies Worldwide (2014) - Percentage Share Breakdown by Value for Jiangsu Hengrui Medicine Co, Ltd., Sanofi S.A., and Others......235
Table 231: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......236
Table 232: Market Shares of Leading Herbal Medicine Manufacturers by Value Sales in Indonesia (2014) - Percentage Breakdown for PT Air Mancur, PT Bintang Toedjoe (KLBF), PT Deltomed Laboratories, PT Industri Jamudan Farmasi Jago, PT Sido Muncul, and Others......237
Table 233: Market Shares of Leading Herbal Products Producers by Value Sales in the US (2014) - Percentage Breakdown for General Nutrition Centres, Inc., GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., NBTY, Inc., Novartis AG, Pfizer, Inc.,Prestige Brands Holdings, Inc., Procter & Gamble Co., Sanofi SA, Private Label and Others......238
Table 234: Market Shares of Leading Letrozole Companies Worldwide (2014) - Percentage Share Breakdown by Value for Jiangsu Hengrui Medicine Co, Ltd., and Novartis International AG......239
Table 235: Market Shares of Leading Orthopedic Sports Medicine Manufacturers by Volume Sales Worldwide (2014) - Percentage Breakdown for Arthrex, Inc., ArthroCare, Biomet, Inc., ConMed Corporation, Johnson & Johnson, Smith & Nephew Plc, Stryker Corporation, Tornier, Inc., and Others......240
Table 236: Market Shares of Leading Prothrombin Complex Companies in China (2014) - Percentage Share Breakdown by Value for Hualan Biological Engineering, Inc., and Shanghai Xinxing Medicine Co, Ltd.......241
Table 237: Market Shares of Leading Specialty Drug Distributors in the US (2014) - Percentage Breakdown by Value for Catamaran Corporation, Caremark, L.L.C., Express Scripts Holding Company, OptumRx, Prime Therapeutics LLC., and Others......242
Table 238: Peritoneal Dialysis Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......243
Table 239: Piperacillin and Tazobactam (Pip Taz) Drug Sales by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for European Union, US and Rest of World......244
Table 240: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2014) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......245
Table 241: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......246
Medical Imaging Equipment......247
Table 242: Market Shares of Leading Imaging Equipment (Advanced, Ultrasound, and X-ray) Manufacturers by Value Sales Worldwide (2014) - Percentage Share Breakdown for General Electric, Koninklijke Philips N.V.,Siemens AG and Others......247
Table 243: Market Shares of Leading Imaging Equipment (Imaging, and Service) Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown For General Electric, Koninklijke Philips N.V., Siemens AG, and Others (Hologic Corporation, and Toshiba Corporation)......248
Table 244: Market Shares of Leading Imaging Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown For General Electric, Koninklijke Philips N.V., Siemens AG, and Others (Hologic Corporation, and Toshiba Corporation)......249
Table 245: Market Shares of Leading Imaging Equipment Service Providers by Value Sales Worldwide (2014) - Percentage Breakdown For General Electric, Koninklijke Philips N.V., Siemens AG, and Others (Hologic Corporation, and Toshiba Corporation)......250
Table 246: Market Shares of Leading Imaging Manufacturers by Value Sales in China (2014) - Percentage Breakdown for China Resources Wandong Medical Equipment Co., Ltd., GE Healthcare, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Ltd., Neusoft Corporation, Ningbo Xingaoyi Co. Ltd., Samsung Group, Shimadzu Corporation, Siemens AG and Toshiba Corporation......251
Table 247: Market Shares of Leading Medical Equipment Manufacturers for Hernia Worldwide (2014) - Percentage Breakdown by Value Sales for C. R. Bard, Inc. (Davol), Ethicon, Inc., Life Cell Corporation (KCI), Synovis Life Technologies (SYNO), US Surgical (COV), W. L. Gore & Associates, Inc., and Others......252
Table 248: Market Shares of Leading Medical Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value for Allengers Medical Systems, Ltd., British Physical Laboratories Group, Dräger Medical, Koninklijke Philips N.V., Siemens AG, Skanray Healthcare Pvt, Ltd., Wipro GE Medical Systems, Ltd., and Others......253
Table 249: Market Shares of Leading Medical Imaging Equipment Manufacturers by Value Sales in Japan (2014) - Percentage Share Breakdown for GE Healthcare, Hitachi Medical Corporation, Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation and Others......254
Table 250: Market Shares of Leading Digital Radiography (Computed Radiography (CR) Included) Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Care stream Health, Inc., General Electric (GE) Company, Koninklijke Philips N.V., Shimadzu Corporation, Siemens AG and Others......255
Gamma-Ray Equipment......256
Table 251: Market Shares of Leading Gamma-Ray Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Agfa Healthcare N.V., Beijing Wandong Medical Equipment Co., Ltd., Carestream Health, Inc., Fujifilm Holdings Corporation, General Electric (GE) Company, Konica Minolta, Inc., Koninklijke Philips N.V., Shimadzu Corporation, Siemens AG, Toshiba Medical Systems Corporation and Others......256
Ultrasound Equipment......257
Table 252: Market Shares of Leading Utrasound Medical Equipment Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Aloka-Trivitron Medical Technologies Ltd, GE Healthcare, Koninklijke Philips N.V., Samsung, Siemens Ltd, and Others......257
Table 253: Market Shares of Leading Premium and High-End Ultrasound Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for General Electric Company, Hitachi-Aloka Medical, Ltd., Koninklijke Philips N.V., Siemens AG, Toshiba Medical Systems Corporation and Others......258
X-Ray Equipment......259
Table 254: Market Shares of Leading X-Ray Imaging Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Share breakdown For General Electric, Koninklijke Philips N.V., Siemens AG and Others......259
Table 255: Market Shares of Leading X-Ray Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GE Healthcare, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Ltd., Samsung Group, Shimadzu Corporation, Siemens AG, Toshiba Corporation and Others......260
Table 256: Market Shares of Leading X-Ray Medical Equipment Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Allengers Medical Systems Limited, Koninklijke Philips N.V., Siemens Ltd, and Others......261
Computed Tomography (CT)......262
Table 257: Market Shares of Leading Computed Tomography (CT) Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GE Healthcare, Hitachi Ltd., Koninklijke Philips N.V., Shimadzu Corporation, Siemens AG and Toshiba Corporation......262
Diagnostic Equipment......263
Table 258: Market Shares of Leading Professional Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories (ABT), Alere, Inc. (ALR), BioMerieux SA (BIM), Danaher Corporation (DHR), F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG (SIE), and Others......263
Table 259: Market Shares of Leading Influenza Diagnostic Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Alere, Inc., Becton, Dickinson and Company, Becton, Dickinson and Company, Quidel Corporation, and Others......264
Table 260: Influenza Diagnostic Equipment Market by Instrument Worldwide (2014) - Percentage Share Breakdown by Value for BinaxNow, Clearview Exact II, Flu A&B, Influenza A+B FIA, QuickVue Influenza A+B, and Others......265
In Vitro Diagnostics (IVD)......266
Table 261: Market Shares of Leading In-Vitro Diagnostics (IVD) Laboratory Service Providers Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bio-Reference Laboratories, Inc., Laboratory Corp. of America Holdings, Myriad Genetics, Inc., Quest Diagnostics, Inc. and Others......266
Table 262: Market Shares of Leading In Vitro Diagnostics (IVD) Laboratory Service Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Quest Diagnostics, Inc. (DGX), Laboratory Corporation of America Holdings (LH), Bio-Reference Laboratories, Inc. (BRLI), Myriad Genetics, Inc. (MYGN), and Others......267
Table 263: Market Shares of Leading In Vitro Diagnostics (IVD) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories (ABT), Alere, Inc. (ALR), Bayer AG (BAYN), Becton, Dickinson and Company (BDX), BioMerieux SA (BIM), Bio-Rad Laboratories, Inc. (BIO), Danaher Corporation (DHR), Hologic, Inc. (HOLX), LifeScan, Inc., Ortho-Clinical Diagnostics, Inc., Rogers Corporation (ROG), Siemens AG (SIE), Sysmex Corporation, Thermo Fisher Scientific (TMO), Werfen Group, and Others......268
Table 264: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Alere, Inc., Danaher Corporation, LifeScan, Inc., Roche Holdings, Inc., System Industrie Electronic GmbH, Thermo Fisher Scientific Inc. and Others......269
Molecular Diagnostics (MDx)......270
Table 265: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......270
Table 266: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories (ABT), Becton, Dickinson and Company (BDX), Cepheid, Inc. (CPHD), Grifols, S.A., Novartis International AG, Hologic, Inc. (HOLX), Illumina, Inc. (ILMN), Qiagen N.V. (QGEN), Rogers Corporation (ROG), Siemens AG (SIE), Thermo Fisher Scientific (TMO), and Others......271
Real Estate......272
Table 267: Market Shares of Leading Online Real Estate Companies in Australia (2014) - Percentage Breakdown by Volume of Time Spent for Fairfax Media Limited, REA Group Ltd. and Others......272
Table 268: Market Shares of Leading Online Real Estate Companies in the US (2014) - Percentage Breakdown by Value Sales for ForRent.com, Move, Inc., Trulia, Inc., and Zillow, Inc.......273
Table 269: Market Shares of Leading Real Estate Companies by Value Sales in (Philadelphia) USA (2014) - Percentage Breakdown for General Growth Properties, Inc. (GGP), Kimco Realty Corp (KIM), MAC, Pennsylvania Real Estate Investment Trust (PEI), and Simon Property Group, Inc. (SPG)......274
Table 270: Market Shares of Leading Real Estate Companies by Value Sales in Japan (2014) - Percentage Breakdown for East Japan Railway Company, Mitsubishi Estate Co., Ltd., Mitsui Fudosan Co., Ltd, Sumitomo Realty & Development Co., Ltd.......275
Logistics......276
Table 271: Market Shares of Leading Contract Logistics and Distribution Service (CL&D) Providers in Asia Pacific (2014) - Percentage Breakdown for CEVA Logistics, Hitachi Transport, Sankyu Inc., Toll Global Logistics, Yamato Holdings, and Others (DHL Supply Chain, Kuehne + Nagel International AG, Mitsubishi Logistics, Nippon Express, SENKO Co. Ltd., and UTi Worldwide Inc.)......276
Table 272: Market Shares of Leading Contract Logistics and Distribution Service (CL&D) Providers in Europe (2014) - Percentage Breakdown for CEVA Logistics , DHL Supply Chain, FIEGE Logistik Holding Stiftung & Co. KG, Kuehne + Nagel International AG, Logwin AG, Norbert Dentressangle, Rhenus AG, SNCF Geodis, Wincanton Plc, and others (Includes DB Schenker Logistics, and UTi Worldwide, Inc.)......277
Table 273: Market Shares of Leading Contract Logistics and Distribution Service (CL&D) Providers in North America (2014) - Percentage Breakdown for CEVA Logistics, DHL Supply Chain, GENCO, Menlo Worldwide, Penske Logistics, Schneider, United Parcel Service of America Inc. (UPS), and others (Includes CAT Logistics, J.B. Hunt Transport Inc., Ryder System Inc., and UTi Worldwide, Inc.)......278
Table 274: Market Shares of Leading Secure Logistics Services Worldwide (2014) - Percentage Share Breakdown by Value for Brink’s Inc., Garda World Security Corporation, Gas, S.A., Loomis, Fargo & Co., Prosegur S.A. and Others......279
Glass Packaging......280
Table 275: Market Shares of Leading Glass Packaging Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Ardagh Group, Owens-Illinois, Inc., and Others......280
Table 276: Market Shares of Leading Glass Packaging Manufacturers by Value Sales in Europe (2014) - Percentage Breakdown for Ardagh Group, Owens-Illinois, Inc., and Others......281